Lussana, F., Gritti, G., Rambaldi, A. (2021). Immunotherapy of acute lymphoblastic leukemia and lymphoma with T cell–redirected bispecific antibodies. JOURNAL OF CLINICAL ONCOLOGY, 39(5), 444-455 [10.1200/JCO.20.01564].

Immunotherapy of acute lymphoblastic leukemia and lymphoma with T cell–redirected bispecific antibodies

Gritti G.;
2021

Articolo in rivista - Review Essay
Antibodies, Bispecific; Clinical Trials, Phase II as Topic; Clinical Trials, Phase III as Topic; Humans; Immunotherapy; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Randomized Controlled Trials as Topic; T-Lymphocytes
English
2021
39
5
444
455
none
Lussana, F., Gritti, G., Rambaldi, A. (2021). Immunotherapy of acute lymphoblastic leukemia and lymphoma with T cell–redirected bispecific antibodies. JOURNAL OF CLINICAL ONCOLOGY, 39(5), 444-455 [10.1200/JCO.20.01564].
File in questo prodotto:
Non ci sono file associati a questo prodotto.

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/10281/529677
Citazioni
  • Scopus 23
  • ???jsp.display-item.citation.isi??? 23
Social impact